- Home
- FG vs CYTK Comparison
FG vs CYTK Comparison
Compare FG & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FG
- CYTK
- Stock Information
- Founded
- FG 1959
- CYTK 1997
- Country
- FG United States
- CYTK United States
- Employees
- FG N/A
- CYTK N/A
- Industry
- FG Life Insurance
- CYTK Biotechnology: Pharmaceutical Preparations
- Sector
- FG Finance
- CYTK Health Care
- Exchange
- FG Nasdaq
- CYTK Nasdaq
- Market Cap
- FG 5.6B
- CYTK 6.0B
- IPO Year
- FG N/A
- CYTK 2004
- Fundamental
- Price
- FG $43.82
- CYTK $48.97
- Analyst Decision
- FG Hold
- CYTK Buy
- Analyst Count
- FG 3
- CYTK 16
- Target Price
- FG $46.33
- CYTK $83.93
- AVG Volume (30 Days)
- FG 53.5K
- CYTK 1.1M
- Earning Date
- FG 11-06-2024
- CYTK 11-06-2024
- Dividend Yield
- FG 2.01%
- CYTK N/A
- EPS Growth
- FG N/A
- CYTK N/A
- EPS
- FG 0.10
- CYTK N/A
- Revenue
- FG $5,834,000,000.00
- CYTK $3,219,000.00
- Revenue This Year
- FG N/A
- CYTK N/A
- Revenue Next Year
- FG N/A
- CYTK $795.25
- P/E Ratio
- FG $447.44
- CYTK N/A
- Revenue Growth
- FG 63.51
- CYTK N/A
- 52 Week Low
- FG $34.90
- CYTK $32.70
- 52 Week High
- FG $50.75
- CYTK $110.25
- Technical
- Relative Strength Index (RSI)
- FG 45.07
- CYTK 43.21
- Support Level
- FG $43.63
- CYTK $47.38
- Resistance Level
- FG $45.35
- CYTK $51.98
- Average True Range (ATR)
- FG 1.52
- CYTK 1.39
- MACD
- FG -0.53
- CYTK -0.14
- Stochastic Oscillator
- FG 14.19
- CYTK 33.33
About FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)) and pension risk transfer (PRT) solutions.
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.